Aurinia Pharmaceuticals, Inc. (AUPH)
15.04
+0.89
(+6.29%)
USD |
NASDAQ |
Mar 04, 16:00
15.14
+0.10
(+0.66%)
After-Hours: 20:00
Aurinia Pharmaceuticals Price : 15.04 for March 4, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Xenon Pharmaceuticals, Inc. | 43.05 |
| Oncolytics Biotech, Inc. | 1.06 |
| Edesa Biotech, Inc. | 4.27 |
| Lexaria Bioscience Corp. | 0.709 |
| ProMIS Neurosciences, Inc. | 24.05 |
Price Related Metrics
| PE Ratio | 7.241 |
| PS Ratio | 7.371 |
| PEG Ratio | 0.0014 |
| Price to Book Value | 3.411 |
| Price to Free Cash Flow | 15.38 |
| Earnings Yield | 13.81% |
| Market Cap | 1.983B |
| PEGY Ratio | 0.0014 |
| Operating PE Ratio | 17.97 |
| Normalized PE Ratio | 7.213 |